Gelteq Limited Ordinary Shares (GELS )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol GELS
- Company Gelteq Limited Ordinary Shares
- Price $2.66
- Changes Percentage -7.64
- Change -0.22
- Day Low $2.35
- Day High $2.81
- Year High $5.5
- Year Low $0.77
- Market Cap $25,105,293
- Price Avg 50 EMA (D) $1.37
- Price Avg 200 EMA (D) $1.98
- Exchange NASDAQ
- Volume 1,653,926
- Average Volume 1,553,051
- Open $2.7
- Previous Close $2.88
- EPS -0.24
- PE -11.08
- Earnings Announcement 1970-01-01 00:00:00
- Shares Outstanding $9,438,080
Company brief: GELTEQ LIMITED ORDINARY SHARES (GELS )
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Mr. Nathan Jacob Givoni
- https://www.gelteq.com
- AU
- N/A
- 11-30--0001
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.